Menu Close
  • Clinical
    • In the Literature
    • Key Clinical Questions
    • Interpreting Diagnostic Tests
    • Coding Corner
    • Clinical
    • Clinical Guidelines
    • COVID-19
    • POCUS
  • Practice Management
    • Quality
    • Public Policy
    • How We Did It
    • Key Operational Question
    • Technology
    • Practice Management
  • Diversity
  • Career
    • Leadership
    • Education
    • Movers and Shakers
    • Career
    • Learning Portal
    • The Hospital Leader Blog
  • Pediatrics
  • HM Voices
    • Commentary
    • In Your Eyes
    • In Your Words
  • SHM Resources
    • Society of Hospital Medicine
    • Journal of Hospital Medicine
    • SHM Career Center
    • SHM Converge
    • Join SHM
    • Converge Coverage
    • SIG Spotlight
    • Chapter Spotlight
    • #JHM Chat
  • Industry Content
    • Patient Monitoring with Tech
An Official Publication of
  • Clinical
    • In the Literature
    • Key Clinical Questions
    • Interpreting Diagnostic Tests
    • Coding Corner
    • Clinical
    • Clinical Guidelines
    • COVID-19
    • POCUS
  • Practice Management
    • Quality
    • Public Policy
    • How We Did It
    • Key Operational Question
    • Technology
    • Practice Management
  • Diversity
  • Career
    • Leadership
    • Education
    • Movers and Shakers
    • Career
    • Learning Portal
    • The Hospital Leader Blog
  • Pediatrics
  • HM Voices
    • Commentary
    • In Your Eyes
    • In Your Words
  • SHM Resources
    • Society of Hospital Medicine
    • Journal of Hospital Medicine
    • SHM Career Center
    • SHM Converge
    • Join SHM
    • Converge Coverage
    • SIG Spotlight
    • Chapter Spotlight
    • #JHM Chat
  • Industry Content
    • Patient Monitoring with Tech

All Content

  • News

    Low IgG levels in COPD patients linked to increased risk of hospitalization

    June 2, 2020

    “Our results raise the possibility that, in select COPD patients, IgG replacement therapy may be effective in reducing the risk of COPD hospitalizations,” the investigators wrote.

  • 1
    News

    Ticagrelor gets FDA nod for DAPT in high-risk patients with CAD

    June 2, 2020

    The new indication is based on THEMIS, which comprised patients with CAD and type 2 diabetes without previous MI or stroke and showed clinical benefit, but also bleeding concerns.

  • 1
    News

    COVID-19: New group stands up for health professionals facing retaliation

    June 2, 2020

    “Doctors, nurses, health care workers are not the typical type to engage politically, to speak out, [or to] advocate for themselves,” said Beacon cofounder Dr. Sejal Hathi.

  • News

    FDA okays emergency use for Impella RP in COVID-19 right heart failure

    June 2, 2020

    The authorization allows use of the temporary heart pump in the treatment of right heart failure or decompensation, including pulmonary embolism, caused by COVID-19 complications.

  • News

    Distancing works, N95 respirators work better

    June 1, 2020

    A meta-analysis confirms that social distancing, face masks, and eye protection significantly reduces the risk of SARS-CoV-2 and COVID-19 spread.

  • Opinion

    COVID-19 ravaging the Navajo Nation

    June 1, 2020

    The Navajo are having to rely on the strength and resilience of traditional Navajo culture and philosophy to confront COVID, said Dr. Mary Hasbah Roessel.

  • News

    10% with diabetes hospitalized for COVID-19 die within a week

    June 1, 2020

    “Even in diabetes, each increase in BMI is associated with an increase in the risk of intubation and/or death in the 7 days following admission for COVID-19.”

  • News

    Mass protests could cause COVID-19 outbreaks

    June 1, 2020

    “There’s going to be a lot of issues coming out of what’s happened in the last week, but one of them is going to be that chains of transmission will have become lit from these gatherings.”

  • 1
    News

    Short medication regimen noninferior to long regimen for rifampin-resistant TB

    June 1, 2020

    Can a randomized trial reproduce results of observational cohort studies for treating rifampin-resistant tuberculosis (TB) with a shorter medication regimen compared to the WHO-­recommended traditional long regimen?

  • News

    Despite guidelines, controversy remains over corticosteroids in COVID-19

    May 29, 2020

    There are conflicting recommendations on the use of corticosteroids in critically ill patients with COVID-19.

Previous1 … 140 141 142 143 144 … 861Next
  • About The Hospitalist
  • Contact Us
  • The Editors
  • Editorial Board
  • Authors
  • Publishing Opportunities
  • Subscribe
  • Advertise
fa-facebookfa-linkedinfa-instagramfa-youtube-playfa-commentfa-envelopefa-rss
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies.
    ISSN 1553-085X
  • Privacy Policy
  • Terms and Conditions
  • SHM’s DE&I Statement
  • Cookie Preferences